IPO Calendar
Upcoming IPOs with underwriters, number of shares, offering price, and timing of the offering. See times when analysts are allowed to rate stocks and when company employees can not sell their stocks after an IPO.
Updated: 05-Mar-26 09:09 ET
Ends: 02-Mar-26 | Co: BOBS
Bob’s Discount Furniture (NYSE) | National, high-growth home furnishings retailer offering stylish, quality furniture at everyday low prices through more than 200 showrooms and a strong omnichannel presence | Opened: 05-Feb-26, $17.00 | Priced: $17.00 | Underwriters: Lead: J.P. Morgan Securities LLC and Morgan Stanley |
Ends: 02-Mar-26 | Co: EIKN
Eikon Therapeutics (Nasdaq) | Late-stage clinical biopharmaceutical firm focused on developing innovative oncology medicines, leveraging advanced biology and engineering to address serious unmet needs in cancer treatment | Opened: 05-Feb-26, $17.05 | Priced: $18.00 | Underwriters: Lead: JPMorgan, Morgan Stanley, BofA Securities, Cantor Fitzgerald & Co. |
Ends: 02-Mar-26 | Co: FPS
Forgent Power Solutions (NYSE) | U.S. manufacturer of custom electrical distribution equipment for data centers, power grids, and industrial facilities | Opened: 05-Feb-26, $26.00 | Priced: $27.00 | Underwriters: Lead: Goldman Sachs & Co. LLC, Jefferies and Morgan Stanley |
Ends: 02-Mar-26 | Co: MANE
Veradermics (NYSE) | Late-stage biopharma developing a novel oral, non-hormonal therapy to improve treatment of pattern hair loss in men and women | Opened: 04-Feb-26, $34.00 | Priced: $17.00 | Underwriters: Lead: Jefferies, Leerink Partners, Citigroup, Cantor Fitzgerald & Co. |
Ends: 03-Mar-26 | Co: AGMB
AgomAb Therapeutics (Nasdaq) | Clinical-stage biopharmaceutical firm developing disease-modifying therapies for immunology and inflammatory diseases, with a focus on fibrotic conditions | Opened: 06-Feb-26, $14.70 | Priced: $16.00 | Underwriters: Lead: J.P. Morgan, Morgan Stanley, Leerink Partners, Van Lanschot Kempen |
Ends: 03-Mar-26 | Co: OFRM
Once Upon a Farm (NYSE) | Organic food brand offering nutritious, kid-friendly meals and snacks made from whole fruits and vegetables | Opened: 06-Feb-26, $21.00 | Priced: $18.00 | Underwriters: Lead: Goldman Sachs & Co. LLC and J.P. Morgan |
Ends: 03-Mar-26 | Co: SGP
SpyGlass Pharma (Nasdaq) | Late-stage biopharmaceutical firm developing long-acting drug delivery solutions for chronic eye diseases | Opened: 06-Feb-26, $24.00 | Priced: $16.00 | Underwriters: Lead: Jefferies, Leerink Partners, Citigroup, Stifel |
Ends: 09-Mar-26 | Co: AGBK
AGI Inc. (NYSE) | Provider of technology-driven financial and credit solutions to underserved consumers in Brazil | Opened: 11-Feb-26, $11.00 | Priced: $12.00 | Underwriters: Lead: Goldman Sachs & Co. LLC, Morgan Stanley, Citigroup |
Ends: 09-Mar-26 | Co: APC
ARKO Petroleum Corp. (Nasdaq) | Fuel distributor and one of North America’s largest wholesale suppliers by volume, serving customers across more than 30 U.S. states | Opened: 12-Feb-26, $17.75 | Priced: $18.00 | Underwriters: Lead: UBS Investment Bank, Raymond James and Stifel |
Ends: 09-Mar-26 | Co: MWH
SOLV Energy (Nasdaq) | Provides EPC and operations services for utility-scale power plants and related grid infrastructure | Opened: 11-Feb-26, $30.00 | Priced: $25.00 | Underwriters: Lead: Jefferies, J.P. Morgan |
Ends: 16-Mar-26 | Co: SHAZ
SharonAI Holdings (Nasdaq) | Holding company created to acquire various assets focused on or in the High Performance Computing industry and AI | Opened: 18-Feb-26, $30.24 | Priced: $30.00 | Underwriters: Lead: Lucid Capital Markets |
Ends: 24-Mar-26 | Co: GENB
Generate Biomedicines (Nasdaq) | Clinical-stage biotech using AI to design novel protein therapeutics, with multiple drug candidates in human trials | Opened: 27-Feb-26, $15.00 | Priced: $16.00 | Underwriters: Lead: Goldman Sachs & Co. LLC, Morgan Stanley, Piper Sandler |
